Detalles de la búsqueda
1.
Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study.
BMC Gastroenterol
; 22(1): 328, 2022 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788189
2.
γ-Glutamyltranspeptidase as a Prognostic Biomarker in Advanced Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
J Vasc Interv Radiol
; 32(3): 419-428.e2, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33067120
3.
Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors.
AJR Am J Roentgenol
; 216(1): 117-124, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32603227
4.
Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis.
Chin J Cancer Res
; 29(1): 36-44, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373752
5.
Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy.
Anticancer Drugs
; 27(2): 118-26, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26566233
6.
Low-dose, short-interval target vessel regional chemotherapy through the hepatic artery combined with transarterial embolization in gastric cancer patients with liver metastases after failure of first-line or second-line chemotherapy: a preliminary analysis.
Anticancer Drugs
; 25(1): 92-100, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24185381
7.
A comparative study between Embosphere(®) and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST.
Chin J Cancer Res
; 26(1): 124-31, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24653635
8.
Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 11: 477-488, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38463543
9.
High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy.
Int Immunopharmacol
; 130: 111767, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430809
10.
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.
Hepatol Int
; 18(1): 4-31, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37864725
11.
[Angiographic findings and interventional therapy for post-pancreaticoduodenectomy hemorrhage].
Zhonghua Yi Xue Za Zhi
; 93(1): 55-7, 2013 Jan 01.
Artículo
en Zh
| MEDLINE | ID: mdl-23578457
12.
A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy.
Transl Oncol
; 34: 101705, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37257332
13.
Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
Chin J Cancer Res
; 24(1): 36-43, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359473
14.
A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases.
Front Oncol
; 12: 913017, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36212504
15.
Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial.
J Nucl Med
; 63(4): 556-559, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34475235
16.
Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma.
Immunotherapy
; 13(17): 1395-1405, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34607482
17.
Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
Biomed Res Int
; 2021: 6670367, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34337041
18.
Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
J Endourol
; 34(10): 1021-1027, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32498630
19.
Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma.
World J Gastrointest Oncol
; 12(6): 663-676, 2020 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32699581
20.
Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma.
World J Gastroenterol
; 26(27): 3975-3988, 2020 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32774071